Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
115.8 INR | +1.85% |
|
+2.81% | +27.41% |
05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+27.41% | 350M | |
+28.57% | 25.55B | |
+13.30% | 24.48B | |
-2.68% | 24.23B | |
-20.72% | 23.67B | |
+30.21% | 19.76B | |
+2.90% | 19.8B | |
-0.87% | 18.97B | |
+45.97% | 18.14B | |
-5.96% | 15.2B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Appoints Mayank Amin as an Independent Additional Director